5th Annual Neuropsychiatric & Psychedelics Drug Development Summit in Boston, MA on October 31st Neuroscience 2022 by the Society of Neuroscience in San Diego, CA on November 13th TORONTO, Oct. 27, 2022 (GLOBE NEWSWIRE) — Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the “Company”), a drug discovery company developing novel, optimized, next-generation psychedelic and non…


Previous articleMINDCURE Announces Financial Results for the First Quarter of Fiscal 2023USA – EnglishUSA – English
Next articleHAVN Life Announces Retail Listing With Loblaws Company Ltd.